Press Releases

Press Releases
Date Title and Summary View
05/27/2012 GAITHERSBURG, Md., April 27, 2012 – GlycoMimetics, Inc. a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, announced today that the ...
05/09/2012 NEW YORK, NY, GAITHERSBURG, MD, and ATHENS, GA, May 9, 2012 – The International AIDS Vaccine Initiative (IAVI), GlycoMimetics, Inc. (GMI), and Glycosensors and Diagnostics, LLC (G&D) today announced a collaboration to develop an AIDS vaccine using novel compounds that mimic carbohydrates, called glycomimetics. The pr...
01/05/2012 GAITHERSBURG, MD, January 5, 2012 – GlycoMimetics, Inc. (GMI), a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that it has promoted Helen Thackray, M.D., to Chief Medical ...
12/13/2011
PDF
Add to Briefcase
10/11/2011
PDF
Add to Briefcase
12/07/2010
PDF
Add to Briefcase
09/28/2010
PDF
Add to Briefcase
07/14/2010
PDF
Add to Briefcase
06/24/2010
PDF
Add to Briefcase
12/07/2009
PDF
Add to Briefcase
FirstPrevious ...
12
NextLast
Add to Briefcase = add release to Briefcase